When is Exjade (deferasirox) indicated for patients with non-transfusion-dependent thalassaemia syndromes aged 10 years and older?

Exjade (deferasirox) is indicated for chronic iron overload requiring chelation therapy when deferoxamine therapy is contraindicated or inadequate in patients with non-transfusion-dependent thalassaemia syndromes aged 10 years and older.